Press Releases and Events
PRESS RELEASES
Press Release | June 2, 2026
Press Release | June 2, 2026
Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations
READ MORE
Press Release | May 22, 2026
Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026
READ MORE
Press Release | May 7, 2026
Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
READ MORE
Press Release | April 27, 2026
Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults
READ MORE
Press Release | April 8, 2026
Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
READ MORE
Press Release | March 26, 2026
Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly
READ MORE
Press Release | February 26, 2026
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
READ MORE
Press Release | February 5, 2026
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March
READ MORE
Press Release | January 26, 2026
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
READ MORE
WEBCAST
PRESS RELEASETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
